Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Invesco Commercial Real Estate Finance Trust, Inc.N/A · Entity 118 | Director | August 31, 2026 | September 02, 2026 |
| Invesco Real Estate Income Trust Inc.NONE · Entity 126 | Director | September 30, 2026 | October 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Invesco Commercial Real Estate Finance Trust, Inc.
Report date August 31, 2026 · Filed September 02, 2026
Jointly reported with Invesco Advisers, Inc., Invesco Group Services, Inc., OppenheimerFunds, Inc., OPPENHEIMER ACQUISITION CORP, IVZ Inc, INVESCO HOLDING CO LTD
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class E Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 515,246.262 |
Reported balance
After 2026-08-31 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-08-31 · Disposition to issuer · Disposed 52,636.636 · Balance 515,246.262 F1: Represents the repurchase of shares of Class E Common Stock held by Invesco Advisers, Inc., which is a wholly owned indirect subsidiary of Invesco Ltd., the ultimate parent entity. The Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the repurchase of shares of Class E Common Stock held by Invesco Advisers, Inc., which is a wholly owned indirect subsidiary of Invesco Ltd., the ultimate parent entity. The Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
Invesco Real Estate Income Trust Inc.
Report date September 30, 2026 · Filed October 02, 2026
Jointly reported with Invesco Advisers, Inc.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class E Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 173,078.39 |
Reported balance
After 2026-09-30 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-09-30 · Disposition to issuer · Disposed 8,969.068 · Balance 173,078.39 F1: Represents the repurchase of shares of Class E Common Stock held by Invesco Advisers, Inc. (IAI), which is a wholly owned indirect subsidiary of Invesco Ltd., the ultimate parent entity. The Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. |
| Class E Common Stock, $0.01 par valueSEC Table I · non-derivative | Direct | 189,253.966 |
Reported balance
After 2026-10-01 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2026-10-01 · Grant · Acquired 16,175.576 · Balance 189,253.966 F2: Represents the acquisition by IAI of Class E Common Stock as payment of its management fee. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the repurchase of shares of Class E Common Stock held by Invesco Advisers, Inc. (IAI), which is a wholly owned indirect subsidiary of Invesco Ltd., the ultimate parent entity. The Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.
F2: Represents the acquisition by IAI of Class E Common Stock as payment of its management fee.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Evofem Biosciences, Inc.
Report date May 14, 2020 · Filed June 09, 2020
Section 16 reporting ended · disclosed 2020-06-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | IndirectSee Footnotes 1 | 12,446,479 |
Reported balance
After 2020-05-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-05-14 · Other · Acquired 78,013 · Balance 12,446,479 F1: Invesco Ltd. acquired the following common shares through its affiliates in a spin off transaction (the "Spin Off Transaction") on May 14, 2020: Invesco FTSE RAFI US 1500 Small-Mid ETF (73,814 shares of common stock); Invesco Buyback Achievers ETF (3,257 shares of common stock); LongView Broad Market 3000 Index Fund (Amalgamated) (923 shares of common stock); and Invesco Purebeta MSCI USA Small Cap ETF (19 shares of common stock). On May 15, 2020 the Invesco Buyback Achievers ETF sold 3,211 shares of Common Stock. On May 26, 2020, the Invesco FTSE RAFI US 1500 Small-Mid ETF sold 73,814 shares of Common Stock, the Invesco Buyback Achievers ETF sold 46 shares of Common Stock and the Invesco Purebeta MSCI USA Small Cap ETF sold 19 shares. |
| Common stockSEC Table I · non-derivative | IndirectSee Footnotes 1 | 12,443,268 |
Reported balance
After 2020-05-15 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2020-05-15 · Sale · Disposed 3,211 · Balance 12,443,268 |
| Common stockSEC Table I · non-derivative | IndirectSee Footnotes 1 | 12,369,454 |
Reported balance
After 2020-05-26 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2020-05-26 · Sale · Disposed 73,814 · Balance 12,369,454 |
| Common stockSEC Table I · non-derivative | IndirectSee Footnotes 1 | 12,369,389 |
Reported balance
After 2020-05-26 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2020-05-26 · Sale · Disposed 65 · Balance 12,369,389 |
| Common stockSEC Table I · non-derivative | IndirectSee Footnotes 2 | 13,226,532 |
Reported balance
After 2020-06-05 transaction · row 5
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 5 · 2020-06-05 · Purchase · Acquired 857,143 · Balance 13,226,532 F2: On June 5, 2020, Invesco Ltd., through its affiliates, the Invesco High Income Fund (UK) and the Invesco Income Fund (UK), purchased 589,302 and 267,841, respectively, of the Issuer's common stock at a price of $3.50 per share as part of the Issuer's registered public offering of 28,500,000 shares. F3: Invesco Ltd. is aware that, under Section 16(b) of the Securities and Exchange Act of 1934, as amended, certain of the sales are matachable against certain purchases of Common Stock. Invesco Ltd. has calculated the aggregate profit to be $174,140.20, using the lowest possible purchase prices and the highest possible sales prices for such trades, and accordingly intends to remit payment to the Company in that amount less transaction costs. |
Filing footnotes · ownership attribution and instrument terms
F1: Invesco Ltd. acquired the following common shares through its affiliates in a spin off transaction (the "Spin Off Transaction") on May 14, 2020: Invesco FTSE RAFI US 1500 Small-Mid ETF (73,814 shares of common stock); Invesco Buyback Achievers ETF (3,257 shares of common stock); LongView Broad Market 3000 Index Fund (Amalgamated) (923 shares of common stock); and Invesco Purebeta MSCI USA Small Cap ETF (19 shares of common stock). On May 15, 2020 the Invesco Buyback Achievers ETF sold 3,211 shares of Common Stock. On May 26, 2020, the Invesco FTSE RAFI US 1500 Small-Mid ETF sold 73,814 shares of Common Stock, the Invesco Buyback Achievers ETF sold 46 shares of Common Stock and the Invesco Purebeta MSCI USA Small Cap ETF sold 19 shares.
F2: On June 5, 2020, Invesco Ltd., through its affiliates, the Invesco High Income Fund (UK) and the Invesco Income Fund (UK), purchased 589,302 and 267,841, respectively, of the Issuer's common stock at a price of $3.50 per share as part of the Issuer's registered public offering of 28,500,000 shares.
F3: Invesco Ltd. is aware that, under Section 16(b) of the Securities and Exchange Act of 1934, as amended, certain of the sales are matachable against certain purchases of Common Stock. Invesco Ltd. has calculated the aggregate profit to be $174,140.20, using the lowest possible purchase prices and the highest possible sales prices for such trades, and accordingly intends to remit payment to the Company in that amount less transaction costs.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2024 Filed May 2, 2024 23:13 UTC | Invesco Real Estate Income Trust Inc. NONE · Entity 126 | GrantClass E Common Stock, $0.01 par value | 5,454 | $29.47 | $160,729.38 |
DisclosureSEC source: 0001976927-24-000015 · wk-form4_1714691608.xml · nonDerivative · entry 2 Invesco Realty, Inc. · CIK 0001992686 · Director Invesco Advisers, Inc. · CIK 0000020430 · Director Invesco Ltd. · CIK 0000914208 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,809 F2 · shares: The Reporting persons are directors by deputization for purpose of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 01, 2024 Filed May 3, 2024 19:35 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | GrantClass E Common Stock, $0.01 par value | 5,792 | $25.10 | $145,385.57 |
DisclosureSEC source: 0001209191-24-005493 · doc4.xml · nonDerivative · entry 1 Invesco Advisers, Inc. · CIK 0000020430 · Director Invesco Group Services, Inc. · CIK 0001993081 · Director OppenheimerFunds, Inc. · CIK 0000728889 · Director OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · Director IVZ Inc · CIK 0001464186 · Director INVESCO HOLDING CO LTD · CIK 0001464185 · Director Invesco Ltd. · CIK 0000914208 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,792 F1 · shares: This Form 4 reports the acquisition by Invesco Advisers, Inc. of Class E Common Stock as payment of its management fee. The Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| April 30, 2024 Filed May 2, 2024 23:13 UTC | Invesco Real Estate Income Trust Inc. NONE · Entity 126 | Disposition to issuerClass E Common Stock, $0.01 par value | 2,820 | $29.47 | $83,105.40 |
DisclosureSEC source: 0001976927-24-000015 · wk-form4_1714691608.xml · nonDerivative · entry 1 Invesco Realty, Inc. · CIK 0001992686 · Director Invesco Advisers, Inc. · CIK 0000020430 · Director Invesco Ltd. · CIK 0000914208 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,355 F1 · shares: These shares are directly held by Invesco Advisers, Inc. Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:31 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | Disposition to issuerClass S Common Stock, $0.01 par value | 997,920.334 | $25.05 | $25,000,000.00 |
DisclosureSEC source: 0001976927-24-000013 · wk-form4_1714681906.xml · nonDerivative · entry 4 Invesco Realty, Inc. · CIK 0001992686 · Director · 10% owner Invesco Group Services, Inc. · CIK 0001993081 · Director · 10% owner OppenheimerFunds, Inc. · CIK 0000728889 · Director · 10% owner OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · Director · 10% owner IVZ Inc · CIK 0001464186 · Director · 10% owner INVESCO HOLDING CO LTD · CIK 0001464185 · Director · 10% owner Invesco Ltd. · CIK 0000914208 · Director · 10% owner Invesco Advisers, Inc. · CIK 0000020430 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,566.257 Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:31 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | Disposition to issuerClass D Common Stock, $0.01 par value | 997,920.334 | $25.05 | $25,000,000.00 |
DisclosureSEC source: 0001976927-24-000013 · wk-form4_1714681906.xml · nonDerivative · entry 3 Invesco Realty, Inc. · CIK 0001992686 · Director · 10% owner Invesco Group Services, Inc. · CIK 0001993081 · Director · 10% owner OppenheimerFunds, Inc. · CIK 0000728889 · Director · 10% owner OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · Director · 10% owner IVZ Inc · CIK 0001464186 · Director · 10% owner INVESCO HOLDING CO LTD · CIK 0001464185 · Director · 10% owner Invesco Ltd. · CIK 0000914208 · Director · 10% owner Invesco Advisers, Inc. · CIK 0000020430 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,566.257 Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:31 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | Disposition to issuerClass I Common Stock, $0.01 par value | 998,825.381 | $25.03 | $24,999,999.99 |
DisclosureSEC source: 0001976927-24-000013 · wk-form4_1714681906.xml · nonDerivative · entry 2 Invesco Realty, Inc. · CIK 0001992686 · Director · 10% owner Invesco Group Services, Inc. · CIK 0001993081 · Director · 10% owner OppenheimerFunds, Inc. · CIK 0000728889 · Director · 10% owner OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · Director · 10% owner IVZ Inc · CIK 0001464186 · Director · 10% owner INVESCO HOLDING CO LTD · CIK 0001464185 · Director · 10% owner Invesco Ltd. · CIK 0000914208 · Director · 10% owner Invesco Advisers, Inc. · CIK 0000020430 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,661.21 Read SEC document |
| April 30, 2024 Filed May 2, 2024 20:31 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | Disposition to issuerClass E Common Stock, $0.01 par value | 995,972.288 | $25.10 | $25,000,000.00 |
DisclosureSEC source: 0001976927-24-000013 · wk-form4_1714681906.xml · nonDerivative · entry 1 Invesco Realty, Inc. · CIK 0001992686 · Director · 10% owner Invesco Group Services, Inc. · CIK 0001993081 · Director · 10% owner OppenheimerFunds, Inc. · CIK 0000728889 · Director · 10% owner OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · Director · 10% owner IVZ Inc · CIK 0001464186 · Director · 10% owner INVESCO HOLDING CO LTD · CIK 0001464185 · Director · 10% owner Invesco Ltd. · CIK 0000914208 · Director · 10% owner Invesco Advisers, Inc. · CIK 0000020430 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,491.317 Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:00 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | PurchaseClass D Common Stock, $0.01 par value | 199,086.591 | $25.11 | $5,000,000.01 |
DisclosureSEC source: 0001209191-23-052021 · doc4.xml · nonDerivative · entry 4 Invesco Realty, Inc. · CIK 0001992686 · 10% owner Invesco Group Services, Inc. · CIK 0001993081 · 10% owner OppenheimerFunds, Inc. · CIK 0000728889 · 10% owner OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · 10% owner IVZ Inc · CIK 0001464186 · 10% owner INVESCO HOLDING CO LTD · CIK 0001464185 · 10% owner Invesco Ltd. · CIK 0000914208 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,052,486.591 F1 · ownership.direct: The shares acquired on October 2, 2023 are owned directly by Invesco Realty, Inc., which is a wholly owned subsidiary of Invesco Advisers, Inc. (the issuer's adviser), which is a wholly owned subsidiary of Invesco Group Services, Inc., which is a wholly owned subsidiary of OppenheimerFunds, Inc., which is a wholly owned subsidiary of Oppenheimer Acquisition Corp., which is a wholly owned subsidiary of Invesco Holding Company (US), Inc., which is a wholly owned subsidiary of Invesco Holding Company Limited and which is a wholly owned subsidiary of Invesco Ltd., the ultimate parent entity. As a result, all entities other than Invesco Realty, Inc. are indirect beneficial owners. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:00 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | PurchaseClass S Common Stock, $0.01 par value | 199,086.591 | $25.11 | $5,000,000.01 |
DisclosureSEC source: 0001209191-23-052021 · doc4.xml · nonDerivative · entry 3 Invesco Realty, Inc. · CIK 0001992686 · 10% owner Invesco Group Services, Inc. · CIK 0001993081 · 10% owner OppenheimerFunds, Inc. · CIK 0000728889 · 10% owner OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · 10% owner IVZ Inc · CIK 0001464186 · 10% owner INVESCO HOLDING CO LTD · CIK 0001464185 · 10% owner Invesco Ltd. · CIK 0000914208 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,052,486.591 F1 · ownership.direct: The shares acquired on October 2, 2023 are owned directly by Invesco Realty, Inc., which is a wholly owned subsidiary of Invesco Advisers, Inc. (the issuer's adviser), which is a wholly owned subsidiary of Invesco Group Services, Inc., which is a wholly owned subsidiary of OppenheimerFunds, Inc., which is a wholly owned subsidiary of Oppenheimer Acquisition Corp., which is a wholly owned subsidiary of Invesco Holding Company (US), Inc., which is a wholly owned subsidiary of Invesco Holding Company Limited and which is a wholly owned subsidiary of Invesco Ltd., the ultimate parent entity. As a result, all entities other than Invesco Realty, Inc. are indirect beneficial owners. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:00 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | PurchaseClass I Common Stock, $0.01 par value | 199,086.591 | $25.11 | $5,000,000.01 |
DisclosureSEC source: 0001209191-23-052021 · doc4.xml · nonDerivative · entry 2 Invesco Realty, Inc. · CIK 0001992686 · 10% owner Invesco Group Services, Inc. · CIK 0001993081 · 10% owner OppenheimerFunds, Inc. · CIK 0000728889 · 10% owner OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · 10% owner IVZ Inc · CIK 0001464186 · 10% owner INVESCO HOLDING CO LTD · CIK 0001464185 · 10% owner Invesco Ltd. · CIK 0000914208 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,052,486.591 F1 · ownership.direct: The shares acquired on October 2, 2023 are owned directly by Invesco Realty, Inc., which is a wholly owned subsidiary of Invesco Advisers, Inc. (the issuer's adviser), which is a wholly owned subsidiary of Invesco Group Services, Inc., which is a wholly owned subsidiary of OppenheimerFunds, Inc., which is a wholly owned subsidiary of Oppenheimer Acquisition Corp., which is a wholly owned subsidiary of Invesco Holding Company (US), Inc., which is a wholly owned subsidiary of Invesco Holding Company Limited and which is a wholly owned subsidiary of Invesco Ltd., the ultimate parent entity. As a result, all entities other than Invesco Realty, Inc. are indirect beneficial owners. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 21:00 UTC | Invesco Commercial Real Estate Finance Trust, Inc. N/A · Entity 118 | PurchaseClass E Common Stock, $0.01 par value | 199,063.605 | $25.12 | $5,000,000.00 |
DisclosureSEC source: 0001209191-23-052021 · doc4.xml · nonDerivative · entry 1 Invesco Realty, Inc. · CIK 0001992686 · 10% owner Invesco Group Services, Inc. · CIK 0001993081 · 10% owner OppenheimerFunds, Inc. · CIK 0000728889 · 10% owner OPPENHEIMER ACQUISITION CORP · CIK 0000869013 · 10% owner IVZ Inc · CIK 0001464186 · 10% owner INVESCO HOLDING CO LTD · CIK 0001464185 · 10% owner Invesco Ltd. · CIK 0000914208 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,052,463.605 F1 · ownership.direct: The shares acquired on October 2, 2023 are owned directly by Invesco Realty, Inc., which is a wholly owned subsidiary of Invesco Advisers, Inc. (the issuer's adviser), which is a wholly owned subsidiary of Invesco Group Services, Inc., which is a wholly owned subsidiary of OppenheimerFunds, Inc., which is a wholly owned subsidiary of Oppenheimer Acquisition Corp., which is a wholly owned subsidiary of Invesco Holding Company (US), Inc., which is a wholly owned subsidiary of Invesco Holding Company Limited and which is a wholly owned subsidiary of Invesco Ltd., the ultimate parent entity. As a result, all entities other than Invesco Realty, Inc. are indirect beneficial owners. Read SEC document |
| September 05, 2023 Filed Sep 8, 2023 01:22 UTC | Invesco Commercial Real Estate Finance Trust, Inc. NONE · Entity 118 | PurchaseClass D Common Stock, $0.01 par value | 700,000 | $25.00 | $17,500,000.00 |
DisclosureSEC source: 0001213900-23-075144 · ownership.xml · nonDerivative · entry 4 Invesco Realty, Inc. · CIK 0001992686 · 10% owner Invesco Advisers, Inc. · CIK 0000020430 · 10% owner Invesco Ltd. · CIK 0000914208 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853,400 F1 · ownership.direct: The Shares acquired on September 5, 2023 are owned directly by Invesco Realty, Inc., which is a wholly owned subsidiary of Invesco Advisers, Inc. (the issuer's adviser), which is a wholly owned subsidiary of Invesco Group Services, Inc., which is a wholly owned subsidiary of OppenheimerFunds, Inc., which is a wholly owned subsidiary of Oppenheimer Acquisition Corp., which is a wholly owned subsidiary of Invesco Holding Company (US), Inc., which is a wholly owned subsidiary of Invesco Holding Company Limited and which is a wholly owned subsidiary of Invesco Ltd., the ultimate parent entity. Thus, all entities other than Invesco Realty, Inc. are indirect beneficial owners. Invesco Group Services, Inc., OppenheimerFunds, Inc., Oppenheimer Acquisition Corp., Invesco Holding Company (US), Inc., and Invesco Holding Company Limited each undertake to file a Form 4 with the Securities and Exchange Commission after receipt of necessary EDGAR Codes. Read SEC document |
| September 05, 2023 Filed Sep 8, 2023 01:22 UTC | Invesco Commercial Real Estate Finance Trust, Inc. NONE · Entity 118 | PurchaseClass S Common Stock, $0.01 par value | 700,000 | $25.00 | $17,500,000.00 |
DisclosureSEC source: 0001213900-23-075144 · ownership.xml · nonDerivative · entry 3 Invesco Realty, Inc. · CIK 0001992686 · 10% owner Invesco Advisers, Inc. · CIK 0000020430 · 10% owner Invesco Ltd. · CIK 0000914208 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853,400 F1 · ownership.direct: The Shares acquired on September 5, 2023 are owned directly by Invesco Realty, Inc., which is a wholly owned subsidiary of Invesco Advisers, Inc. (the issuer's adviser), which is a wholly owned subsidiary of Invesco Group Services, Inc., which is a wholly owned subsidiary of OppenheimerFunds, Inc., which is a wholly owned subsidiary of Oppenheimer Acquisition Corp., which is a wholly owned subsidiary of Invesco Holding Company (US), Inc., which is a wholly owned subsidiary of Invesco Holding Company Limited and which is a wholly owned subsidiary of Invesco Ltd., the ultimate parent entity. Thus, all entities other than Invesco Realty, Inc. are indirect beneficial owners. Invesco Group Services, Inc., OppenheimerFunds, Inc., Oppenheimer Acquisition Corp., Invesco Holding Company (US), Inc., and Invesco Holding Company Limited each undertake to file a Form 4 with the Securities and Exchange Commission after receipt of necessary EDGAR Codes. Read SEC document |
| September 05, 2023 Filed Sep 8, 2023 01:22 UTC | Invesco Commercial Real Estate Finance Trust, Inc. NONE · Entity 118 | PurchaseClass I Common Stock, $0.01 par value | 700,000 | $25.00 | $17,500,000.00 |
DisclosureSEC source: 0001213900-23-075144 · ownership.xml · nonDerivative · entry 2 Invesco Realty, Inc. · CIK 0001992686 · 10% owner Invesco Advisers, Inc. · CIK 0000020430 · 10% owner Invesco Ltd. · CIK 0000914208 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853,400 F1 · ownership.direct: The Shares acquired on September 5, 2023 are owned directly by Invesco Realty, Inc., which is a wholly owned subsidiary of Invesco Advisers, Inc. (the issuer's adviser), which is a wholly owned subsidiary of Invesco Group Services, Inc., which is a wholly owned subsidiary of OppenheimerFunds, Inc., which is a wholly owned subsidiary of Oppenheimer Acquisition Corp., which is a wholly owned subsidiary of Invesco Holding Company (US), Inc., which is a wholly owned subsidiary of Invesco Holding Company Limited and which is a wholly owned subsidiary of Invesco Ltd., the ultimate parent entity. Thus, all entities other than Invesco Realty, Inc. are indirect beneficial owners. Invesco Group Services, Inc., OppenheimerFunds, Inc., Oppenheimer Acquisition Corp., Invesco Holding Company (US), Inc., and Invesco Holding Company Limited each undertake to file a Form 4 with the Securities and Exchange Commission after receipt of necessary EDGAR Codes. Read SEC document |
| September 05, 2023 Filed Sep 8, 2023 01:22 UTC | Invesco Commercial Real Estate Finance Trust, Inc. NONE · Entity 118 | PurchaseClass E Common Stock, $0.01 par value | 700,000 | $25.00 | $17,500,000.00 |
DisclosureSEC source: 0001213900-23-075144 · ownership.xml · nonDerivative · entry 1 Invesco Realty, Inc. · CIK 0001992686 · 10% owner Invesco Advisers, Inc. · CIK 0000020430 · 10% owner Invesco Ltd. · CIK 0000914208 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 853,400 F1 · ownership.direct: The Shares acquired on September 5, 2023 are owned directly by Invesco Realty, Inc., which is a wholly owned subsidiary of Invesco Advisers, Inc. (the issuer's adviser), which is a wholly owned subsidiary of Invesco Group Services, Inc., which is a wholly owned subsidiary of OppenheimerFunds, Inc., which is a wholly owned subsidiary of Oppenheimer Acquisition Corp., which is a wholly owned subsidiary of Invesco Holding Company (US), Inc., which is a wholly owned subsidiary of Invesco Holding Company Limited and which is a wholly owned subsidiary of Invesco Ltd., the ultimate parent entity. Thus, all entities other than Invesco Realty, Inc. are indirect beneficial owners. Invesco Group Services, Inc., OppenheimerFunds, Inc., Oppenheimer Acquisition Corp., Invesco Holding Company (US), Inc., and Invesco Holding Company Limited each undertake to file a Form 4 with the Securities and Exchange Commission after receipt of necessary EDGAR Codes. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 10:49 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | PurchaseCommon stock | 857,143 | $3.50 | $3,000,000.50 |
DisclosureSEC source: 0001209191-20-035184 · doc4.xml · nonDerivative · entry 5 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes 2 Disclosed balance after: 13,226,532 F2 · kind: On June 5, 2020, Invesco Ltd., through its affiliates, the Invesco High Income Fund (UK) and the Invesco Income Fund (UK), purchased 589,302 and 267,841, respectively, of the Issuer's common stock at a price of $3.50 per share as part of the Issuer's registered public offering of 28,500,000 shares. F3 · kind: Invesco Ltd. is aware that, under Section 16(b) of the Securities and Exchange Act of 1934, as amended, certain of the sales are matachable against certain purchases of Common Stock. Invesco Ltd. has calculated the aggregate profit to be $174,140.20, using the lowest possible purchase prices and the highest possible sales prices for such trades, and accordingly intends to remit payment to the Company in that amount less transaction costs. Read SEC document |
| May 26, 2020 Filed Jun 9, 2020 10:49 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | SaleCommon stock | 65 | $5.98 | $388.70 |
DisclosureSEC source: 0001209191-20-035184 · doc4.xml · nonDerivative · entry 4 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes 1 Disclosed balance after: 12,369,389 Read SEC document |
| May 26, 2020 Filed Jun 9, 2020 10:49 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | SaleCommon stock | 73,814 | $5.79 | $427,383.06 |
DisclosureSEC source: 0001209191-20-035184 · doc4.xml · nonDerivative · entry 3 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes 1 Disclosed balance after: 12,369,454 Read SEC document |
| May 15, 2020 Filed Jun 9, 2020 10:49 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | SaleCommon stock | 3,211 | $5.04 | $16,183.44 |
DisclosureSEC source: 0001209191-20-035184 · doc4.xml · nonDerivative · entry 2 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes 1 Disclosed balance after: 12,443,268 Read SEC document |
| May 14, 2020 Filed Jun 9, 2020 10:49 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | OtherCommon stock | 78,013 | $5.13 | $400,206.69 |
DisclosureSEC source: 0001209191-20-035184 · doc4.xml · nonDerivative · entry 1 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes 1 Disclosed balance after: 12,446,479 F1 · kind: Invesco Ltd. acquired the following common shares through its affiliates in a spin off transaction (the "Spin Off Transaction") on May 14, 2020: Invesco FTSE RAFI US 1500 Small-Mid ETF (73,814 shares of common stock); Invesco Buyback Achievers ETF (3,257 shares of common stock); LongView Broad Market 3000 Index Fund (Amalgamated) (923 shares of common stock); and Invesco Purebeta MSCI USA Small Cap ETF (19 shares of common stock). On May 15, 2020 the Invesco Buyback Achievers ETF sold 3,211 shares of Common Stock. On May 26, 2020, the Invesco FTSE RAFI US 1500 Small-Mid ETF sold 73,814 shares of Common Stock, the Invesco Buyback Achievers ETF sold 46 shares of Common Stock and the Invesco Purebeta MSCI USA Small Cap ETF sold 19 shares. Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:41 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | OtherRight to Purchase · Derivative | 555,556 | $0.00 Strike: $6.38 | $55.56 |
DisclosureSEC source: 0001209191-19-036289 · doc4.xml · derivative · entry 3 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 555,556 Underlying: Common Stock · 555,556 shares Expires not disclosed F5 · kind: On June 10, 2019, Invesco Ltd. exercised its right, pursuant to that certain Securities Purchase Agreement between the Issuer, Invesco Ltd., PLD Biopharma, and Woodford Asset Management Limited dated April 10, 2019 (the "Securities Purchase Agreement"), to purchase (i) 2,222,222 shares of common stock at a purchase price of $4.50 per share and (ii) warrants to purchase 555,556 shares of common stock at a purchase price equal to $6.38 per share. F6 · derivative.exercise_date: The warrants are exercisable six (6) months following the original issue date. F7 · derivative.expiration_date: The warrants expire seven (7) years following the original issue date. F1 · ownership.nature: Invesco Ltd. is the beneficial owner of 11,812,910 shares of common stock and warrants to purchase 555,556 common shares acquired by its affiliates, Invesco High Income Fund(UK) and Invesco Income Fund(UK). Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:41 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | OtherWarrants · Derivative | 212,765 | $0.00 Strike: $5.20 | $21.28 |
DisclosureSEC source: 0001209191-19-036289 · doc4.xml · derivative · entry 2 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 555,556 Underlying: Common Stock · 212,765 shares Expires 2026-02-08 F2 · kind: Pursuant to the Securities Purchase Agreement, Invesco Ltd. agreed to cancel warrants to purchase 212,765 shares of Common Stock. F2 · shares: Pursuant to the Securities Purchase Agreement, Invesco Ltd. agreed to cancel warrants to purchase 212,765 shares of Common Stock. F3 · derivative.exercise_date: The warrants were exercisable on the earlier of 08/08/2019, or following the date that the issuance of the warrants was approved by the stockholders of the Issuer. F4 · ownership.nature: Invesco Ltd. owned the warrants through its affiliates, Invesco High Income Fund (UK) and Invesco Income Fund (UK). Read SEC document |
| June 10, 2019 Filed Jun 12, 2019 14:41 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | PurchaseCommon stock | 2,222,222 | $4.50 | $9,999,999.00 |
DisclosureSEC source: 0001209191-19-036289 · doc4.xml · nonDerivative · entry 1 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 11,812,910 F1 · ownership.nature: Invesco Ltd. is the beneficial owner of 11,812,910 shares of common stock and warrants to purchase 555,556 common shares acquired by its affiliates, Invesco High Income Fund(UK) and Invesco Income Fund(UK). Read SEC document |
| April 10, 2019 Filed Apr 15, 2019 19:33 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | OtherRight to Purchase · Derivative | 555,556 | $0.00 Strike: $6.38 | $55.56 |
DisclosureSEC source: 0001209191-19-024559 · doc4.xml · derivative · entry 2 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,777,778 Underlying: Common Stock · 555,556 shares Expires not disclosed F1 · kind: On April 10, 2019, Invesco Ltd. entered into a Securities Purchase Agreement with the Issuer (the "Securities Purchase Agreement"), pursuant to which Invesco Ltd. has the right, until June 10, 2019, to purchase 2,222,222 shares of common stock at a purchase price of $4.50 per share and warrants to purchase an additional 555,556 shares of common stock at an exercise price equal to $6.38 per share. F4 · derivative.exercise_date: The warrants are exercisable six (6) months following the original issue date F5 · derivative.expiration_date: The warrants expire seven (7) years following the original issue date. F2 · balance_after: This number does not include the 212,765 warrants owned by Invesco Ltd. as of the date of this Form 4. Pursuant to the Securities Purchase Agreement, upon and subject to the second closing contemplated therein, Invesco Ltd. will surrender for cancellation warrants to purchase 212,765 shares of common stock existing and outstanding as of the date of the Securities Purchase Agreement. F3 · ownership.nature: Invesco Ltd. is the beneficial owner of 11,812,910 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco High Income Fund and Invesco Income Fund. Read SEC document |
| April 10, 2019 Filed Apr 15, 2019 19:33 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | OtherRight to Purchase · Derivative | 2,222,222 | $0.00 Strike: $4.50 | $222.22 |
DisclosureSEC source: 0001209191-19-024559 · doc4.xml · derivative · entry 1 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,777,778 Underlying: Common Stock · 2,222,222 shares Expires 2019-06-10 F1 · kind: On April 10, 2019, Invesco Ltd. entered into a Securities Purchase Agreement with the Issuer (the "Securities Purchase Agreement"), pursuant to which Invesco Ltd. has the right, until June 10, 2019, to purchase 2,222,222 shares of common stock at a purchase price of $4.50 per share and warrants to purchase an additional 555,556 shares of common stock at an exercise price equal to $6.38 per share. F2 · balance_after: This number does not include the 212,765 warrants owned by Invesco Ltd. as of the date of this Form 4. Pursuant to the Securities Purchase Agreement, upon and subject to the second closing contemplated therein, Invesco Ltd. will surrender for cancellation warrants to purchase 212,765 shares of common stock existing and outstanding as of the date of the Securities Purchase Agreement. F3 · ownership.nature: Invesco Ltd. is the beneficial owner of 11,812,910 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco High Income Fund and Invesco Income Fund. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:05 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | PurchaseWarrants · Derivative | 212,765 | $0.00 Strike: $5.20 | $21.28 |
DisclosureSEC source: 0001209191-19-009273 · doc4.xml · derivative · entry 2 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 212,765 Underlying: Common Stock · 212,765 shares Expires 2026-02-08 F2 · derivative.exercise_date: The warrants are exercisable on the earlier of 08/08/2019, or following the date that the issuance of the warrants is approved by the stockholders of the Issuer. F1 · ownership.nature: Invesco Ltd. is the beneficial owner of 9,590,688 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund. Read SEC document |
| February 08, 2019 Filed Feb 12, 2019 21:05 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | PurchaseCommon stock | 425,531 | $2.64 | $1,123,401.84 |
DisclosureSEC source: 0001209191-19-009273 · doc4.xml · nonDerivative · entry 1 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 9,590,688 F1 · ownership.nature: Invesco Ltd. is the beneficial owner of 9,590,688 shares of common stock and warrants to purchase 212,765 common shares acquired by its affiliates, Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund. Read SEC document |
| May 22, 2018 Filed May 24, 2018 19:32 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | PurchaseWarrants · Derivative | 2,127,659 | $0.01 Strike: $7.50 | $21,276.59 |
DisclosureSEC source: 0001209191-18-032950 · doc4.xml · derivative · entry 2 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes (2), (3) and (4) Disclosed balance after: 2,127,659 Underlying: Common stock · 425,531 shares Expires 2018-05-24 F1 · kind: The common stock and warrants were purchased from the underwriters in a public offering pursuant to a registration statement on Form S-1 (333- 224958). The shares of common stock and warrants were purchased at the public offering price. Read SEC document |
| May 22, 2018 Filed May 24, 2018 19:32 UTC | Evofem Biosciences, Inc. EVFM · Entity 8607 | PurchaseCommon stock, Par value $0.0001 per share | 2,127,659 | $4.69 | $9,978,720.71 |
DisclosureSEC source: 0001209191-18-032950 · doc4.xml · nonDerivative · entry 1 Invesco Ltd. · CIK 0000914208 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 9,165,157 F1 · kind: The common stock and warrants were purchased from the underwriters in a public offering pursuant to a registration statement on Form S-1 (333- 224958). The shares of common stock and warrants were purchased at the public offering price. F2 · ownership.nature: Invesco Ltd. is the beneficial owner of 9,165,157 shares of common stock and 2,127,659 warrants acquired by its affiliates, Invesco Perpetual High Income Funda and Invesco Perpetual Income Fund. F3 · ownership.nature: Invesco Asset Management Ltd. is a subsidiary of Invesco Ltd., and it advises Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund. F4 · ownership.nature: As described in the Neothetics, Inc. Registration Statement on Form S-4 (File No. 333-221592) voting and investment power over the common stock and warrants held by Invesco Perpetual High Income Fund and Invesco Perpetual Income Fund is exercised by the directors of Invesco Asset Management Ltd. Neothetics, Inc. changed its name to Evofem Biosciences, Inc. on January 17, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.